You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

NEOSAR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Neosar, and when can generic versions of Neosar launch?

Neosar is a drug marketed by Bedford and Teva Parenteral and is included in two NDAs.

The generic ingredient in NEOSAR is cyclophosphamide. There are nineteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Neosar

A generic version of NEOSAR was approved as cyclophosphamide by BAXTER HLTHCARE on May 21st, 2008.

  Try a Trial

Drug patent expirations by year for NEOSAR
Recent Clinical Trials for NEOSAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Adam KittaiPhase 2
Joseph TuscanoPhase 2
ADC TherapeuticsPhase 2

See all NEOSAR clinical trials

US Patents and Regulatory Information for NEOSAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford NEOSAR cyclophosphamide INJECTABLE;INJECTION 087442-004 Jul 8, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Parenteral NEOSAR cyclophosphamide INJECTABLE;INJECTION 040015-005 Apr 29, 1993 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bedford NEOSAR cyclophosphamide INJECTABLE;INJECTION 087442-002 Feb 16, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Parenteral NEOSAR cyclophosphamide INJECTABLE;INJECTION 040015-001 Apr 29, 1993 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bedford NEOSAR cyclophosphamide INJECTABLE;INJECTION 087442-005 Mar 30, 1989 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bedford NEOSAR cyclophosphamide INJECTABLE;INJECTION 087442-001 Feb 16, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.